<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B15D18A8-63A8-4893-8F4A-0A3BE4D2C583"><gtr:id>B15D18A8-63A8-4893-8F4A-0A3BE4D2C583</gtr:id><gtr:name>Karus Therapeutics</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8044C2F3-70A8-44B3-A919-3A5ADEFD2311"><gtr:id>8044C2F3-70A8-44B3-A919-3A5ADEFD2311</gtr:id><gtr:name>Francis Crick Institute</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/E1649C06-DC81-4A08-8A23-F5B65BB6C670"><gtr:id>E1649C06-DC81-4A08-8A23-F5B65BB6C670</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:department>UNLISTED</gtr:department><gtr:address><gtr:line1>Babraham Research Campus</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB22 3AT</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E1649C06-DC81-4A08-8A23-F5B65BB6C670"><gtr:id>E1649C06-DC81-4A08-8A23-F5B65BB6C670</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:address><gtr:line1>Babraham Research Campus</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB22 3AT</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B15D18A8-63A8-4893-8F4A-0A3BE4D2C583"><gtr:id>B15D18A8-63A8-4893-8F4A-0A3BE4D2C583</gtr:id><gtr:name>Karus Therapeutics</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8044C2F3-70A8-44B3-A919-3A5ADEFD2311"><gtr:id>8044C2F3-70A8-44B3-A919-3A5ADEFD2311</gtr:id><gtr:name>Francis Crick Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/A8FFE8BD-0636-4C9D-A5F7-29460A47D865"><gtr:id>A8FFE8BD-0636-4C9D-A5F7-29460A47D865</gtr:id><gtr:firstName>Len</gtr:firstName><gtr:surname>Stephens</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BBS%2FE%2FB%2F0000H235"><gtr:id>4BDA0A91-DB3B-4D83-A3D0-123AAFCE9E98</gtr:id><gtr:title>P13K signalling; the rules of engagement</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>BBS/E/B/0000H235</gtr:grantReference><gtr:abstractText>Nearly all of the cells of our bodies contain three related proteins called PI3K alpha, PI3K beta and PI3K delta. We now know these PI3Ks play a very important role in transmitting information from hormones outside of the cell to the inside of cells. This information is needed for the cell to co-ordinate various complex responses to the hormone, such as cell growth, survival or movement. The key aim of this project is to define the roles for PI3Ks in a type of white blood cell called a neutrophil.</gtr:abstractText><gtr:fund><gtr:end>2014-01-18</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2009-01-19</gtr:start><gtr:type>EXPENDITURE_PROJECTED</gtr:type><gtr:valuePounds>264011</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Francis Crick Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Downward_RBD of Class I PI3Ks</gtr:description><gtr:id>5402C819-6160-47B6-988F-9828AF81CE29</gtr:id><gtr:impact>Houslay et al (2016) Sci Signal. 16;9(441):ra82. doi: 10.1126/scisignal.aae0453.</gtr:impact><gtr:outcomeId>58b443ca901eb6.20872123-1</gtr:outcomeId><gtr:partnerContribution>They provided genetically engineered mouse embryonic fibroblast cell lines with mutations in the Ras Binding Domain (RBD) of Class I PI3K alpha and beta.</gtr:partnerContribution><gtr:piContribution>We designed the study and performed all experiments</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Karus Therapeutics</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Steve Shuttleworth</gtr:description><gtr:id>8525EA37-F642-43B5-AD98-FE9FD8C7C5ED</gtr:id><gtr:impact>See other outputs, some of the data is provided in the from of reports to Karus, some is published.</gtr:impact><gtr:outcomeId>56bb2a7e70be92.78806598-1</gtr:outcomeId><gtr:partnerContribution>They have provided funding and inhibitors.</gtr:partnerContribution><gtr:piContribution>We have performed research with neutrophils and xenografts and PI3K inhibitors and genetically modified mice to study the role of PI3Ks in immune function in inflammation and tumours.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Work experience for year 12 school students</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>F7524A08-D52C-40A0-97EC-25EA5CF04398</gtr:id><gtr:impact>Work shadowing for a yr 12 school student to understand biomedical research

Student applied and got an offer on a biomedical degree course</gtr:impact><gtr:outcomeId>54624afb870e31.83032049</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited lecturer to international meetings (average 2-3 per year)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C0454D1A-A1D4-4E20-A8FE-29DC92BA93B6</gtr:id><gtr:impact>promoted discussions, collaborations

scientific collaborations, joint grants and publications</gtr:impact><gtr:outcomeId>546215ce564be0.43637759</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>Pre-2006,2006,2007,2008,</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We have established that it is possible to use a genetic approach in mice to isolate specifc pi3k complexes from mouse tissues. previously this had proved very difficult because of technical issues with the use of bacterial DNA in mammalian cells, that we have now solved.</gtr:description><gtr:exploitationPathways>This approach allows use of avi-tagging technology in mice to isolate any protein that is placed in frame with an avi-tag (15aa). It uses transgenically expressed BirA with mammalised codon usage (ROSA locus) to achieve efficient biotinylation of the tag in all mouse tissues tested. It has already been exported to a number of ther labs and underpins a lot of further work at BI on other funding. The apporach is very powerful and we are discussing further application with companies.</gtr:exploitationPathways><gtr:id>20552145-CB80-451C-A88D-4B99E2510FB5</gtr:id><gtr:outcomeId>56bb24624f4821.47879941</gtr:outcomeId><gtr:sectors><gtr:sector>Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>57664310-6058-4654-A614-97766FD55971</gtr:id><gtr:title>Emerging evidence of signalling roles for PI(3,4)P2 in Class I and II PI3K-regulated pathways.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d3df4506683f973bcc340d59b4b4a5e"><gtr:id>9d3df4506683f973bcc340d59b4b4a5e</gtr:id><gtr:otherNames>Hawkins PT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>58b439901d0341.87001628</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8FD69C46-7239-4C51-A08C-952961529B9D</gtr:id><gtr:title>Signalling via class IA PI3Ks.</gtr:title><gtr:parentPublicationTitle>Advances in enzyme regulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98fc59721084558256aa857c43566d4c"><gtr:id>98fc59721084558256aa857c43566d4c</gtr:id><gtr:otherNames>Stephens L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0065-2571</gtr:issn><gtr:outcomeId>5463715d27e3e7.66332345</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07B7FF53-D5A5-468C-81B5-4B53261067B4</gtr:id><gtr:title>PTEN Regulates PI(3,4)PSignaling Downstream of Class I PI3K.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32166a1af7e300ccef30545562aeb163"><gtr:id>32166a1af7e300ccef30545562aeb163</gtr:id><gtr:otherNames>Malek M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>5a7c6eb7c1cd71.88477176</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4245DBD-230C-4439-A582-CB06A2A88EBC</gtr:id><gtr:title>PI3K signalling: the path to discovery and understanding.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Molecular cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e8ef3720a283f60669bc6948866244e"><gtr:id>6e8ef3720a283f60669bc6948866244e</gtr:id><gtr:otherNames>Vanhaesebroeck B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-0072</gtr:issn><gtr:outcomeId>doi_55f94d94d60d10de</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03AB40FB-1EF2-485F-9C17-2B473BBA637D</gtr:id><gtr:title>Class (I) Phosphoinositide 3-Kinases in the Tumor Microenvironment.</gtr:title><gtr:parentPublicationTitle>Cancers</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a9dbc474049ae4add6a52c620827b2ca"><gtr:id>a9dbc474049ae4add6a52c620827b2ca</gtr:id><gtr:otherNames>Gyori D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2072-6694</gtr:issn><gtr:outcomeId>5a980f8852aff1.08957333</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9F6FDE2-82BE-45C4-BDCC-75CCF1C671EA</gtr:id><gtr:title>PI3K? plays a critical role in neutrophil activation by immune complexes.</gtr:title><gtr:parentPublicationTitle>Science signaling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf4791aaad3ff17c7499e3c358e997f1"><gtr:id>bf4791aaad3ff17c7499e3c358e997f1</gtr:id><gtr:otherNames>Kulkarni S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1945-0877</gtr:issn><gtr:outcomeId>5463715dc834f6.41347250</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>882DE46F-BAD9-4907-95DF-E2B29FFA93B1</gtr:id><gtr:title>PTEN Regulates PI(3,4)PSignaling Downstream of Class I PI3K.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32166a1af7e300ccef30545562aeb163"><gtr:id>32166a1af7e300ccef30545562aeb163</gtr:id><gtr:otherNames>Malek M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>5a980f87e3e100.94220490</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BBS/E/B/0000H235</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>